Consulta: subjectFacets:"Potency assays"
Registros recuperados: 1
Data/hora: 11/06/2024 05:46:07

Development of potency assays for a plasmid containing vascular endothelial growth factor 2
Provedor de dados: 69
Autores: Huang,Li-chun; Chin,Emily; Chiang,Yawen L.
We have developed analytical methods to measure the biological functions of pVGI.1(VEGF2), a naked plasmid DNA product containing vascular endothelial growth factor 2 used in clinical trials for coronary artery diseases (CAD) and peripheral artery diseases (PAD). After being injected into muscles, vascular endothelial growth factor 2 (VEGF-2), presumably expressed in muscle tissues, binds to the endothelial cell receptors VEGFR2 or VEGFR3, triggering the downstream responses including cell proliferation and vascularization. As it is important to make sure clinical material is biological active, we developed a quantitative assay first to measure the receptor binding activity of the pVGI.1(VEGF2) gene product expressed by the transfected host cells, and then...
Tipo: Journal article
Palavras-chave: Cell proliferation; Plasmid DNA; Potency assays; Receptor binding; VEGF-2.
Ano: 2010
URL: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582010000100001